COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2157: Articles 21561-21570  | Next

Saliva as testing sample for SARS-CoV-2 detection by RT-PCR in low prevalence community setting.
Gavars, D., Gavars, M., Perminovs, D., Stasulans, J., Stana, J., Metla, Z., Pavare, J., Tauckels, E., Gulbis, E., Dumpis, U.
10.1101/2020.10.20.20216127 — Posted: 2020-10-21
Innate Immune Response Modulation and Resistance to SARS-CoV-2 infection: A Prospective Comparative Cohort Study in High Risk Healthcare Workers
Jaiswal, D. S. R., Mehta, A., Bhagwati, D. G., Lakhchaura, M. R., Aiyer, D. H., Khamar, D. B. M., Chakrabarti, D. S.
10.1101/2020.10.20.20214965 — Posted: 2020-10-21
PERFORMANCE EVALUATION OF A SARS-COV-2 RAPID ANTIGENTEST: TEST PERFORMANCE IN THE COMMUNITY IN THE NETHERLANDS
Van der Moeren, N., Zwart, V., Lodder, E., Van den Bijllaardt, W., Van Esch, H., Stohr, J., Pot, J., Welschen, I., Van Mechelen, P., Pas, S., Kluytmans, J.
10.1101/2020.10.19.20215202 — Posted: 2020-10-21
Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys high throughput immunoassay
Mulchandani, R., Brown, B., Brooks, T., Semper, A., Machin, N., Linley, E., Borrow, R., Study Investigators, E.-H., Wyllie, D.
10.1101/2020.10.19.20215228 — Posted: 2020-10-21
Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York
Kamath, K., Baum-Jones, E., Jordan, G., Haynes, W., Waitz, R., Shon, J., Kujawa, S., Fitzgibbons, L., Kessler, D., Luchsinger, L. L., Yale IMPACT Team, , Daugherty, P.
10.1101/2020.10.19.20215368 — Posted: 2020-10-21
The Causal Effect of Air Pollution on COVID-19 Transmission: Evidence from China
He, G., PAN, Y., Tanaka, T.
10.1101/2020.10.19.20215236 — Posted: 2020-10-21
Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score
Chua, F., Vancheeswaran, R., Draper, A., Vaghela, T., Knight, M., Moghal, R., Singh, J., Spencer, L. G., Thwaite, E., Mitchell, H., Calmonson, S., Mahdi, N., Assadullah, S., Leung, M., O'Neill, A., Popat, C., Kumar, R., Humphries, T. J., Talbutt, R., Raghunath, S., Molyneaux, P. L., Schechter, M., Lowe, J., Barlow, A.
10.1101/2020.10.19.20215426 — Posted: 2020-10-21
Deep learning segmentation model for automated detection of the opacity regions in the chest X-rays of the Covid-19 positive patients and the application for disease severity
Tang, H., Sun, N., Li, Y.
10.1101/2020.10.19.20215483 — Posted: 2020-10-21
Differential Impact of Mitigation Policies and Socioeconomic Status on COVID-19 Prevalence and Social Distancing in the United States
Chang, H.-Y., Tang, W., Hatef, E., Kitchen, C., Weiner, J. P., Kharrazi, H.
10.1101/2020.10.20.20216119 — Posted: 2020-10-21
Effect of park use and landscape structure on COVID-19 transmission rates
Johnson, T. F., Hordley, L. A., Greenwell, M. P., Evans, L. C.
10.1101/2020.10.20.20215731 — Posted: 2020-10-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).